An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.

In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...

Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...

Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...